Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 472

1.

The association between non-alcoholic fatty liver disease and valvular heart disease.

Mari A, Khoury T, Said Ahmad H, Abu Baker F, Kadah A, Sbeit W, Pellicano R, Mahamid M.

Minerva Cardioangiol. 2019 Nov 28. doi: 10.23736/S0026-4725.19.05087-4. [Epub ahead of print]

PMID:
31789009
2.

Risk of drug interactions and prescription appropriateness in elderly patients.

Petrini E, Caviglia GP, Pellicano R, Saracco GM, Morino M, Ribaldone DG.

Ir J Med Sci. 2019 Nov 30. doi: 10.1007/s11845-019-02148-8. [Epub ahead of print]

PMID:
31786720
3.

Eosinophilic esophagitis: pitfalls and controversies in diagnosis and management.

Mari A, Abu Baker F, Mahamid M, Khoury T, Sbeit W, Pellicano R.

Minerva Med. 2019 Nov 12. doi: 10.23736/S0026-4806.19.06322-5. [Epub ahead of print]

PMID:
31755670
4.

History of Inflammatory Bowel Diseases.

Actis GC, Pellicano R, Fagoonee S, Ribaldone DG.

J Clin Med. 2019 Nov 14;8(11). pii: E1970. doi: 10.3390/jcm8111970. Review.

5.

Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn's disease: application of Lémann Index.

Ribaldone DG, Caviglia GP, Pellicano R, Vernero M, Italia A, Morino M, Saracco GM, Astegiano M.

Scand J Gastroenterol. 2019 Nov;54(11):1339-1345. doi: 10.1080/00365521.2019.1686057. Epub 2019 Nov 6.

PMID:
31692395
6.

Does the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome?

Fagoonee S, Pellicano R.

J Clin Med. 2019 Oct 30;8(11). pii: E1808. doi: 10.3390/jcm8111808.

7.

Early detection of hepatocellular carcinoma in alcoholic liver disease.

Borro P, Testino G, Pellicano R, Caputo F.

Panminerva Med. 2019 Oct 25. doi: 10.23736/S0031-0808.19.03763-7. [Epub ahead of print] No abstract available.

PMID:
31670497
8.

Human microbiota and inflammatory bowel diseases: new pieces of an intricate puzzle.

Pellicano R.

Minerva Gastroenterol Dietol. 2019 Sep;65(3):171-172. doi: 10.23736/S1121-421X.19.02616-3. Epub 2019 Oct 9. No abstract available.

PMID:
31602969
9.

Which role for blue light emitting diodes for the treatment of Helicobacter pylori?

Pellicano R.

Minerva Gastroenterol Dietol. 2019 Sep;65(3):175-176. doi: 10.23736/S1121-421X.19.02612-6. Epub 2019 Oct 9. No abstract available.

PMID:
31602968
10.

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease.

Ribaldone DG, Caviglia GP, Abdulle A, Pellicano R, Ditto MC, Morino M, Fusaro E, Saracco GM, Bugianesi E, Astegiano M.

J Clin Med. 2019 Oct 9;8(10). pii: E1646. doi: 10.3390/jcm8101646.

11.

Risk factors of suspected spondyloarthritis among inflammatory bowel disease patients.

Ribaldone DG, Vernero M, Parisi S, Ditto MC, Pellicano R, Morino M, Saracco GM, Fusaro E, Astegiano M.

Scand J Gastroenterol. 2019 Oct;54(10):1233-1236. doi: 10.1080/00365521.2019.1668052. Epub 2019 Sep 24.

PMID:
31549896
12.

Inflammation in gastrointestinal disorders: prevalent socioeconomic factors.

Ribaldone DG, Pellicano R, Actis GC.

Clin Exp Gastroenterol. 2019 Jul 19;12:321-329. doi: 10.2147/CEG.S210844. eCollection 2019.

13.

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients.

Ribaldone DG, Adriani A, Caviglia GP, Nicolò A, Agnesod D, Simiele M, Riganò D, Pellicano R, Canaparo R, Perri GD, D'Avolio A, Luzza F, Saracco GM, Astegiano M.

Medicina (Kaunas). 2019 Aug 5;55(8). pii: E441. doi: 10.3390/medicina55080441.

14.

Management of addiction medicine: sharing medicine?

Bottaro LC, Leone S, Sampietro L, Balbinot P, Pellicano R, Testino G.

Minerva Med. 2019 Jul 30. doi: 10.23736/S0026-4806.19.06257-8. [Epub ahead of print] No abstract available.

PMID:
31359740
15.

Infections with Helicobacter pylori and challenges encountered in Africa.

Smith S, Fowora M, Pellicano R.

World J Gastroenterol. 2019 Jul 7;25(25):3183-3195. doi: 10.3748/wjg.v25.i25.3183. Review.

16.

Real-time PCR detection of Toxoplasma gondii in tissue samples of wild boars (Sus scrofa) from southern Italy reveals high prevalence and parasite load.

Santoro M, Viscardi M, Sgroi G, DʼAlessio N, Veneziano V, Pellicano R, Brunetti R, Fusco G.

Parasit Vectors. 2019 Jul 5;12(1):335. doi: 10.1186/s13071-019-3586-5.

17.

Dentistry and oral and maxillofacial surgery in the patient with liver disease: key messages for clinical practice.

Brigo S, Mancuso E, Pellicano R.

Minerva Stomatol. 2019 Aug;68(4):192-199. doi: 10.23736/S0026-4970.19.04216-X. Epub 2019 May 27.

PMID:
31140770
18.

Non-invasive assessment of liver fibrosis in HCV patients compared to liver biopsy: the experience of tertiary level Hospital in Serbia.

Preveden T, Vereš B, Ružić M, Pete M, Luzza F, Pellicano R, Abenavoli L.

Minerva Med. 2019 May 6. doi: 10.23736/S0026-4806.19.06109-3. [Epub ahead of print]

PMID:
31081313
19.

Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study.

Rosso C, Caviglia GP, Ciruolo M, Ciancio A, Younes R, Olivero A, Giordanino C, Troshina G, Abate ML, Rizzetto M, Pellicano R, Saracco GM, Bugianesi E, Smedile A.

Minerva Med. 2019 Oct;110(5):401-409. doi: 10.23736/S0026-4806.19.06108-1. Epub 2019 May 6.

PMID:
31081312
20.

Gut microbiota and chronic exercise in diabetic patients: not only bacteria.

Ribaldone DG, Pellicano R.

Minerva Med. 2019 May 6. doi: 10.23736/S0026-4806.19.06090-7. [Epub ahead of print] No abstract available.

PMID:
31081308
21.

Helicobacter pylori eradication: the relevance of a periodic update.

Ribaldone DG, Pellicano R.

Ann Gastroenterol. 2019 May-Jun;32(3):320. doi: 10.20524/aog.2019.0362. Epub 2019 Feb 15. No abstract available.

22.

The gut and the Inflammatory Bowel Diseases inside-out: the extra-intestinal manifestations.

Ribaldone DG, Pellicano R, Actis GC.

Minerva Gastroenterol Dietol. 2019 Apr 16. doi: 10.23736/S1121-421X.19.02577-7. [Epub ahead of print]

PMID:
30994321
23.

Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis.

Ribaldone DG, Pellicano R, Vernero M, Caviglia GP, Saracco GM, Morino M, Astegiano M.

Scand J Gastroenterol. 2019 Apr;54(4):407-413. doi: 10.1080/00365521.2019.1597159. Epub 2019 Apr 4.

PMID:
30945576
24.

Alcohol-related chronic exocrine pancreatic insufficiency: diagnosis and therapeutic management. A proposal for treatment by the Italian Association for the Study of the Pancreas (AISP) and the Italian Society of Alcohology (SIA).

Pezzilli R, Caputo F, Testino G, Patussi V, Greco G, Macciò L, Rossin MR, Mioni D, Balbinot P, Gandin C, Zanesini F, Frulloni L, Aricò S, Bottaro LC, Pellicano R, Scafato E; Italian Society of Alcohology (SIA).

Minerva Med. 2019 Oct;110(5):425-438. doi: 10.23736/S0026-4806.19.06043-9. Epub 2019 Apr 1. Review.

PMID:
30938130
25.

Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study.

Vernero M, Boano V, Ribaldone DG, Pellicano R, Astegiano M.

Minerva Gastroenterol Dietol. 2019 Sep;65(3):200-203. doi: 10.23736/S1121-421X.19.02572-8. Epub 2019 Mar 27.

26.

Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review.

Fagoonee S, Pellicano R.

Infect Dis (Lond). 2019 Jun;51(6):399-408. doi: 10.1080/23744235.2019.1588472. Epub 2019 Mar 25.

PMID:
30907202
27.

Helicobacter pylori prevalence: Are the data totally reliable?

Ribaldone DG, Vernero M, Pellicano R.

J Pediatr Surg. 2019 Jun;54(6):1261. doi: 10.1016/j.jpedsurg.2018.12.026. Epub 2019 Feb 16. No abstract available.

PMID:
30824241
28.

Health and governance: towards a new management of the medicine of sharing.

Bottaro LC, Sampietro L, Pellicano R, Testino G.

Minerva Med. 2019 Jun;110(3):188-190. doi: 10.23736/S0026-4806.19.06007-5. Epub 2019 Feb 14. No abstract available.

PMID:
30784255
29.

Atrial fibrillation and alcoholic beverages.

Testino G, Leone S, Pellicano R.

Minerva Med. 2019 Oct;110(5):471-472. doi: 10.23736/S0026-4806.19.05958-5. Epub 2019 Feb 14. No abstract available.

PMID:
30784247
30.

Alcohology: a medical specialization in real practice.

Testino G, Balbinot P, Pellicano R.

Minerva Med. 2019 Jun;110(3):185-187. doi: 10.23736/S0026-4806.19.05954-8. Epub 2019 Feb 14. No abstract available.

PMID:
30784246
31.

The role of topical therapy for perianal fistulizing Crohn's disease: are we forgetting something?

Ribaldone DG, Resegotti A, Pellicano R, Astegiano M, Saracco GM, Morino M.

Minerva Gastroenterol Dietol. 2019 Jun;65(2):130-135. doi: 10.23736/S1121-421X.19.02565-0. Epub 2019 Feb 12.

PMID:
30759975
32.

Inflammatory bowel disease and alcohol consumption.

Testino G, Leone S, Balbinot P, Fagoonee S, Pellicano R.

Minerva Gastroenterol Dietol. 2019 Jun;65(2):82-84. doi: 10.23736/S1121-421X.19.02560-1. Epub 2019 Feb 11. No abstract available.

PMID:
30746928
33.

Irritable bowel syndrome: a real-world picture of the USA.

Adriani A, Saracco GM, Pellicano R.

Minerva Gastroenterol Dietol. 2019 Jun;65(2):79-81. doi: 10.23736/S1121-421X.19.02558-3. Epub 2019 Feb 11. No abstract available.

PMID:
30746926
34.

Liver transplantation: a new era.

Testino G, Leone S, Pellicano R.

Minerva Gastroenterol Dietol. 2019 Jun;65(2):163-164. doi: 10.23736/S1121-421X.19.02555-8. Epub 2019 Feb 11. No abstract available.

PMID:
30746925
35.

Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients.

Ribaldone DG, Fagoonee S, Astegiano M, Durazzo M, Morgando A, Sprujevnik T, Giordanino C, Baronio M, De Angelis C, Saracco GM, Pellicano R.

J Clin Med. 2019 Feb 6;8(2). pii: E199. doi: 10.3390/jcm8020199.

36.

The type of dyspepsia is important in the context of patients with irritable bowel syndrome and gastroesophageal reflux disease.

Pellicano R.

J Formos Med Assoc. 2019 Apr;118(4):849. doi: 10.1016/j.jfma.2019.01.005. Epub 2019 Jan 19. No abstract available.

37.

A Comment on Anti-Helicobacter pylori Therapy and Autoimmune Diseases.

Pellicano R.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1647. doi: 10.1016/j.cgh.2019.01.016. Epub 2019 Jan 17. No abstract available.

PMID:
30660588
38.

Comment on "Factors Associated with Recurrent Ulcers in Patients with Gastric Surgery after More Than 15 Years: A Cross-Sectional Single-Center Study".

Ribaldone DG, Pellicano R.

Gastroenterol Res Pract. 2018 Dec 16;2018:8356948. doi: 10.1155/2018/8356948. eCollection 2018. No abstract available.

39.

When is it useful to act on microbiota in atopic children? A recent experience.

Pellicano R, Cisarò F, Durazzo M, Ribaldone DG.

Minerva Pediatr. 2019 Feb;71(1):1-3. doi: 10.23736/S0026-4946.18.05425-7. No abstract available.

40.

Is microbiome a target for the management of allergy associated diseases in children?

Ribaldone DG, Vernero M, Pellicano R.

Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8061-8062. doi: 10.26355/eurrev_201812_16494. No abstract available.

41.

Microscopic colitis: a narrative review with clinical approach.

Mosso E, Boano V, Grassini M, Battaglia E, Pellicano R.

Minerva Gastroenterol Dietol. 2019 Mar;65(1):53-62. doi: 10.23736/S1121-421X.18.02539-4. Epub 2018 Nov 21. Review.

PMID:
30486642
42.

Liver diseases in the elderly.

Durazzo M, Ponzo E, Bonetto S, Fagoonee S, Pellicano R.

Minerva Med. 2019 Feb;110(1):35-51. doi: 10.23736/S0026-4806.18.05858-5. Epub 2018 Oct 11. Review.

PMID:
30334441
43.

Lifestyle factors among adolescent.

Balbinot P, Fagoonee S, Pellicano R, Testino G.

Minerva Pediatr. 2018 Dec;70(6):642-643. doi: 10.23736/S0026-4946.18.05386-0. Epub 2018 Oct 4. No abstract available.

PMID:
30299029
44.

Prevalence of Helicobacter pylori infection among dyspeptic patients with and without type 2 diabetes mellitus in Nigeria.

Smith SI, Jolaiya T, Onyekwere C, Fowora M, Ugiagbe R, Agbo I, Cookey C, Lesi O, Ndububa D, Adekanle O, Palamides P, Adeleye I, Njom H, Idowu A, Clarke A, Pellicano R.

Minerva Gastroenterol Dietol. 2019 Mar;65(1):36-41. doi: 10.23736/S1121-421X.18.02528-X. Epub 2018 Oct 2.

PMID:
30293417
45.

Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease.

Faletti R, Ribaldone DG, Gatti M, Perazzini C, Robella M, Angelino F, Saracco GM, Astegiano M, Pellicano R, Fonio P.

Rev Esp Enferm Dig. 2019 Jan;111(1):28-33. doi: 10.17235/reed.2018.5691/2018.

46.

Irritable bowel syndrome: the clinical approach.

Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano R.

Panminerva Med. 2018 Dec;60(4):213-222. doi: 10.23736/S0031-0808.18.03541-3. Epub 2018 Sep 24. Review.

47.

Risk of incident melanoma in patients with inflammatory disease treated with anti-TNF: the Turin experience.

Vernero M, Ribaldone DG, Astegiano M, Pellicano R.

G Ital Dermatol Venereol. 2018 Sep 20. doi: 10.23736/S0392-0488.18.06017-0. [Epub ahead of print] No abstract available.

PMID:
30249085
48.

Alcoholic liver fibrosis: detection and treatment.

Testino G, Leone S, Fagoonee S, Pellicano R.

Minerva Med. 2018 Dec;109(6):457-471. doi: 10.23736/S0026-4806.18.05844-5. Epub 2018 Sep 13. Review.

PMID:
30221911
49.

Helicobacter pylori and nonmalignant upper gastrointestinal diseases.

Jonaitis L, Pellicano R, Kupcinskas L.

Helicobacter. 2018 Sep;23 Suppl 1:e12522. doi: 10.1111/hel.12522. Review.

PMID:
30203583
50.

Infections and stroke: Which potential pathogenic mechanism?

Ribaldone DG, Pellicano R.

Int J Stroke. 2019 Jan;14(1):NP1. doi: 10.1177/1747493018801219. Epub 2018 Sep 10. No abstract available.

PMID:
30198832

Supplemental Content

Loading ...
Support Center